| Dr Nancy Ann Tanchel, MD | |
|
8321 Old Courthouse Rd, Liberty Laser Eye Center, Vienna, VA 22182-3817 | |
| (571) 234-5678 | |
| Not Available |
| Full Name | Dr Nancy Ann Tanchel |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 8321 Old Courthouse Rd, Vienna, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629112107 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 0101225245 (Virginia) | Primary |
| Entity Name | The Eye Institute Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194986182 PECOS PAC ID: 3072929876 Enrollment ID: O20210302002227 |
News Archive
School closures during COVID-19 have decreased access to school meals, which is likely to increase the risk for food insecurity among children in Maryland, according to a new report issued by researchers at the University of Maryland School of Medicine (UMSOM).
The ATS has released an official policy statement of pay-for-performance (P4P) in pulmonary, critical care and sleep medicine. In the statement, the Society encourages clinicians in these fields to participate in P4P programs and views them as an opportunity to partner with healthcare payors, accrediting organizations, governmental oversight groups and others to improve quality, rather than as a threat to autonomy and independence.
Cannabis Science Inc., an emerging pharmaceutical cannabis company, is reviewing interim results of its survey from over 1400 people, US military veterans and others who responded to our PTSD survey. The survey is still available for a limited time online on the www.cannabisscience.com website for all those who still wish to participate.
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nancy Ann Tanchel, MD 8321 Old Courthouse Rd, Liberty Laser Eye Center, Vienna, VA 22182-3817 Ph: (571) 234-5678 | Dr Nancy Ann Tanchel, MD 8321 Old Courthouse Rd, Liberty Laser Eye Center, Vienna, VA 22182-3817 Ph: (571) 234-5678 |
News Archive
School closures during COVID-19 have decreased access to school meals, which is likely to increase the risk for food insecurity among children in Maryland, according to a new report issued by researchers at the University of Maryland School of Medicine (UMSOM).
The ATS has released an official policy statement of pay-for-performance (P4P) in pulmonary, critical care and sleep medicine. In the statement, the Society encourages clinicians in these fields to participate in P4P programs and views them as an opportunity to partner with healthcare payors, accrediting organizations, governmental oversight groups and others to improve quality, rather than as a threat to autonomy and independence.
Cannabis Science Inc., an emerging pharmaceutical cannabis company, is reviewing interim results of its survey from over 1400 people, US military veterans and others who responded to our PTSD survey. The survey is still available for a limited time online on the www.cannabisscience.com website for all those who still wish to participate.
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
› Verified 1 days ago
Dr. Lisa Framm Sklar, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 302 Maple Ave W, Vienna, VA 22180 Phone: 703-938-1201 Fax: 703-938-3563 | |
Anouche M. Roberts, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 9818 Wintercress Ct, Vienna, VA 22182 Phone: 703-757-0748 | |
Dr. Daniel Herschel Framm, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 302 Maple Ave W, Vienna, VA 22180 Phone: 703-938-1201 Fax: 703-938-3563 | |
Dr. Bella Dave Patnaik, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8150 Leesburg Pike #909, Vienna, VA 22182 Phone: 703-790-1780 Fax: 703-734-0491 | |
Dr. Julie Freidlin Leigh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8150 Leesburg Pike, Suite #909, Vienna, VA 22182 Phone: 703-790-1780 Fax: 703-734-0491 | |
Dr. Jung John Woo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8233 Old Courthouse Rd, Suite 300, Vienna, VA 22182 Phone: 703-917-0012 Fax: 703-917-0028 | |
Dr. Carl J Leto, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8150 Leesburg Pike, Suite 909, Vienna, VA 22182 Phone: 703-790-1780 Fax: 703-734-0491 |